Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zegerid vs Losec for Rapid Relief of Heartburn in GERD
NCT01493089Phase 3Completed
- Sponsor
- Norgine
- Start
- Apr 2011
- Primary completion
- Oct 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of omeprazole in gastroesophageal reflux disease (GERD), sponsored by Norgine. Started Apr 2011; status: completed.
02
Drugs
omeprazole
03
Conditions
gastroesophageal reflux disease (GERD)
Beyond the preview
Go deeper on NCT01493089.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01493089.